Ilya M. Rachman
CEO and Chairman at Immix Biopharma Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Immix Biopharma Inc., 3 years.
Immix Biopharma Inc.
Director · CEO and Chairman
Chief executive roles
Immix Biopharma Inc.
· CEO and Chairman
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 10, 2025 | Immix Biopharma Inc. | Open-market purchase | +746 | $6.67 | $4,976 |
| Sep 17, 2025 | Immix Biopharma Inc. | Open-market purchase | +2,500 | $2.02 | $5,050 |
| Jun 18, 2025 | Immix Biopharma Inc. | Open-market purchase | +2,178 | $2.30 | $5,009 |
| Jun 7, 2024 | Immix Biopharma Inc. | Open-market purchase | +2,600 | $2.13 | $5,538 |
| Jun 4, 2024 | Immix Biopharma Inc. | Open-market purchase | +3,300 | $1.81 | $5,973 |
| May 20, 2024 | Immix Biopharma Inc. | Grant or award | +218,359 | — | — |
| May 14, 2024 | Immix Biopharma Inc. | Open-market purchase | +4,300 | $2.25 | $9,675 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.